Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Masimo Corp (NQ: MASI )

126.89 +2.79 (+2.25%)
Streaming Delayed Price Updated: 11:44 AM EDT, May 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Masimo Corp

< Previous 1 2 3 4 5 6 7 8 9 Next >
CORRECTING and REPLACING Masimo Board of Directors Authorizes Appointment of Michelle Brennan as Sixth Director Pending Stockholder Approval of Board Expansion and Election of Company Nominees
From Masimo Corporation
Via Business Wire
Masimo Board of Directors Sets the Record Straight on False and Misleading Claims
From Masimo
Via Business Wire
Masimo Files Investor Presentation Highlighting Track Record of Success, Compelling Strategy, Responsive Governance Changes and Risks Posed by Quentin Koffey’s Agenda
From Masimo
Via Business Wire
Masimo Corp. (NASDAQ: MASI) Records 52-Week High Thursday Morning
Via Investor Brand Network
Politan Releases Investor Presentation Detailing Why New Directors Are Needed on the Masimo Board and Responds to Company’s Disingenuous Claims
From Politan Capital Management
Via Business Wire
Masimo Board of Directors Files Definitive Proxy and Issues Letter to Stockholders
From Masimo
Via Business Wire
Masimo Announces Major Expansion of the HEOS® Platform
From Masimo
Via Business Wire
Politan Calls on Shareholders to Elect Independent Oversight to Masimo’s Board
From Politan Capital Management
Via Business Wire
Orange County Business Journal Names Masimo’s Micah Young CFO of the Year
From Masimo
Via Business Wire
Masimo Reports First Quarter 2023 Financial Results
From Masimo
Via Business Wire
Cambridge University Hospitals Expands Virtual Care Program with Masimo W1™
From Masimo
Via Business Wire
Politan Nominates Two Candidates for Masimo Board
From Politan Capital Management
Via Business Wire
Masimo Stork™ Delivers State-of-the-Art Baby Monitoring to the Home
From Masimo
Via Business Wire
Masimo to Report First Quarter 2023 Financial Results After Market Close on Tuesday, May 9
From Masimo
Via Business Wire
Masimo Announces FDA Clearance of the Rad-G® with Temperature
From Masimo
Via Business Wire
Masimo Opioid Halo™ Granted De Novo for the First and Only FDA-Authorized Opioid Overdose Prevention and Alert System
From Masimo
Via Business Wire
Masimo Unveils the Future of Health Tracking and Smart Wearables with the Pre-Sale Launch of the Freedom™ Smartwatch
From Masimo
Via Business Wire
Masimo Announces Changes to Governance Structure and Practices
From Masimo Corporation
Via Business Wire
European Society of Anaesthesiology and Intensive Care (ESAIC) Recommends Noninvasive, Continuous Hemoglobin Monitoring
From Masimo
Via Business Wire
New Study Finds That Masimo PVi® Reliably Predicted Fluid Responsiveness in Young Children Undergoing Neurosurgery
From Masimo
Via Business Wire
Masimo and Temple Health Form Innovation Collaboration with Focus on Hospital Automation and Telehealth Initiatives
From Masimo
Via Business Wire
New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients
From Masimo
Via Business Wire
CalSTRS Joins Politan Capital Management in Legal Action Against Masimo CEO’s Employment Agreement
From Politan Capital Management
Via Business Wire
Masimo to Present in 44th Annual Raymond James Institutional Investors Conference
From Masimo
Via Business Wire
Masimo Reports Fourth Quarter and Full-Year 2022 Financial Results
From Masimo
Via Business Wire
New Study Evaluates the Utility of Masimo ORi™ in Reducing Hyperoxemia During Laparoscopic Gastrectomy
From Masimo
Via Business Wire
Masimo Centroid® Receives Innovative Technology Designation from Vizient
From Masimo
Via Business Wire
Masimo to Report Fourth Quarter and FY 2022 Financial Results After Market Close on Tuesday, February 28
From Masimo
Via Business Wire
Masimo Announces the Limited Market Release of Visual Clinical Activity Monitoring (VCAM™)
From Masimo
Via Business Wire
Researchers Harness the Power of Masimo Root®’s Advanced Multimodal Monitoring Capabilities to Study the Impact of Different Ventilatory Strategies on Brain Oxygenation During Thoracoscopic Surgery
From Masimo
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.